Patent application number | Description | Published |
20090062282 | Substituted Amino-Pyrimidones and Uses Thereof - This invention relates to novel compounds having the structural formula Ia or formula Ib below: (Ia, Ib), and their pharmaceutically acceptable salts, tautomers or in vivo hydrolysable precursors, compositions and methods of use thereof. These novel compounds provide a treatment or prophylaxis of Aβ related pathologies such as cognitive impairment, Alzheimer Disease, neurodegeneration and dementia. | 03-05-2009 |
20090076020 | Cyclopropyl Amide Derivatives 978 - Disclosed herein is at least one cyclopropyl amide derivative, at least one pharmaceutical composition comprising at least one cyclopropyl amide derivative disclosed herein, and at least one method of using at least one cyclopropyl amide derivative disclosed herein for treating at least one histamine H3 receptor associated condition therewith. | 03-19-2009 |
20090221579 | Substituted Amino-Compounds and Uses Thereof - This invention relates to novel compounds having the structural formula Ia or formula Ib: Ia Ib and their pharmaceutically acceptable salts, tautomers or in vivo hydrolysable precursors, compositions and methods of use thereof. These novel compounds provide a treatment or prophylaxis of Aβ related pathologies such as cognitive impairment, Alzheimer Disease, neurodegeneration and dementia. | 09-03-2009 |
20090306158 | Metabotropic Glutamate Receptor Isoxazole Ligands and Their Use as Potentiators 286 - Compounds in accord with Formula I: | 12-10-2009 |
20100022545 | Metabotropic Glutamate Receptor Isoxazole Ligands and Their Use as Potentiators - 286 - Compounds in accord with Formula I: | 01-28-2010 |
20100317662 | Metabotropic Glutamate Receptor Isoxazole Ligands and Their Use as Potentiators - 286 - Compounds in accord with Formula I: | 12-16-2010 |
20100324044 | METABOTROPIC GLUTAMATE RECEPTOR ISOXAZOLE LIGANDS AND THEIR USE AS POTENTIATORS - Compounds in accord with Formula I: | 12-23-2010 |
20120065193 | Cyclopropyl Amide Derivatives '978 - Disclosed herein is at least one cyclopropyl amide derivative, at least one pharmaceutical composition comprising at least one cyclopropyl amide derivative disclosed herein, and at least one method of using at least one cyclopropyl amide derivative disclosed herein for treating at least one histamine H3 receptor associated condition therewith. | 03-15-2012 |